Shimla: Last year in Janaury, the licence for producing vaccines of Central Research Institute (CRI), Kasauli, was canceled by the Central Government on the ground that one hundred and three year old institute was not accomplishing the goods manufacturing practice requirements as per the norms of the World Health Organisation (WHO) but now ministry has asked CRI to resume production.
“A decision for resumption of vaccine production at the CRI was taken by the union ministry of health and family welfare last week. The ministry has conveyed to the CRI for restarting the production of vaccines. It (the ministry) has also decided to initiate steps to modernise the CRI as per WHO requirements,” MP D.R. Shandil told IANS.
When ministry banned the CRI, supply of vaccines worth Rs. 20 crore was also bunged up, later coping the shortage of vaccines in the country it asked the CRI to release the stocks in March, 2008.
Sources said that the decision to restart the production of vaccines was taken due to shortage of vaccines again in the country.
The CRI was manufacturing vaccines for yellow fever, diphtheria, measles, typhoid and tetanus. It was the only producer of the yellow fever vaccine in South Asia and the major producer of the anti-sera.
However, the CRI is yet to receive any communication from the central ministry regarding the resumption of production.